| Seasonal influenza vaccine in immunocompromised persons M Bosaeed, D Kumar Human vaccines & immunotherapeutics 14 (6), 1311-1322, 2018 | 118 | 2018 |
| Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial M Bosaeed, A Alharbi, E Mahmoud, S Alrehily, M Bahlaq, Z Gaifer, ... Clinical Microbiology and infection 28 (4), 602-608, 2022 | 103 | 2022 |
| Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality J Alghamdi, M Alaamery, T Barhoumi, M Rashid, H Alajmi, N Aljasser, ... Genomics 113 (4), 1733-1741, 2021 | 58 | 2021 |
| Ceftobiprole for treatment of MRSA blood stream infection: A case series E Mahmoud, S Al Mansour, M Bosaeed, A Alharbi, A Alsaedy, S Aljohani, ... Infection and Drug Resistance, 2667-2672, 2020 | 47 | 2020 |
| Knowledge and attitude of physicians toward prescribing antibiotics and the risk of resistance in two reference hospitals A Alothman, A Algwizani, M Alsulaiman, A Alalwan, S Binsalih, ... Infectious Diseases: Research and Treatment 9, IDRT. S40047, 2016 | 46 | 2016 |
| Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial M Bosaeed, HH Balkhy, S Almaziad, HA Aljami, H Alhatmi, H Alanazi, ... The Lancet Microbe 3 (1), e11-e20, 2022 | 45 | 2022 |
| Early prediction of COVID-19 ventilation requirement and mortality from routinely collected baseline chest radiographs, laboratory, and clinical data with machine learning AF Aljouie, A Almazroa, Y Bokhari, M Alawad, E Mahmoud, E Alawad, ... Journal of Multidisciplinary Healthcare, 2017-2033, 2021 | 34 | 2021 |
| Nationwide seroprevalence of SARS-CoV-2 in Saudi arabia NK Alharbi, S Alghnam, A Algaissi, H Albalawi, MW Alenazi, ... Journal of infection and public health 14 (7), 832-838, 2021 | 34 | 2021 |
| Viruses causing aseptic meningitis: a tertiary medical center experience with a multiplex PCR assay MA Aldriweesh, EA Shafaay, SM Alwatban, OM Alkethami, FN Aljuraisi, ... Frontiers in Neurology 11, 602267, 2020 | 26 | 2020 |
| Favipiravir and hydroxychloroquine combination therapy in patients with moderate to severe COVID-19 (FACCT Trial): an open-label, multicenter, randomized, controlled trial M Bosaeed, E Mahmoud, A Alharbi, H Altayib, H Albayat, F Alharbi, ... Infectious Diseases and Therapy 10, 2291-2307, 2021 | 22 | 2021 |
| Developing machine-learning prediction algorithm for bacteremia in admitted patients E Mahmoud, M Al Dhoayan, M Bosaeed, S Al Johani, YM Arabi Infection and drug resistance, 757-765, 2021 | 20 | 2021 |
| Experience With Ceftolozane-Tazobactam for the Treatment of Serious Pseudomonas aeruginosa Infections in Saudi Tertiary Care Center M Bosaeed, A Ahmad, A Alali, E Mahmoud, L Alswidan, A Alsaedy, ... Infectious Diseases: Research and Treatment 13, 1178633720905977, 2020 | 20 | 2020 |
| COVID-19 reinfection: A multicenter retrospective study in Saudi Arabia NA Shaheen, R Sambas, M Alenezi, NK Alharbi, O Aldibasi, M Bosaeed Annals of Thoracic Medicine 17 (2), 81-86, 2022 | 15 | 2022 |
| Persistence of anti-SARS-CoV-2 Spike IgG antibodies following COVID-19 vaccines NK Alharbi, JA Al-Tawfiq, A Alwehaibe, MW Alenazi, A Almasoud, ... Infection and Drug Resistance, 4127-4136, 2022 | 13 | 2022 |
| Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19 M Bosaeed, A Alharbi, M Hussein, M Abalkhail, K Sultana, A Musattat, ... BMJ open 11 (4), e047495, 2021 | 13 | 2021 |
| Melioidosis: case reports of confirmed Burkholderia pseudomallei in Saudi Arabia H Alhatmi, A Alharbi, M Bosaeed, O Aldosary, S Aljohani, B Alalwan, ... Journal of Infection and Public Health 13 (5), 824-826, 2020 | 13 | 2020 |
| Outcomes of single dose COVID-19 vaccines: eight month follow-up of a large cohort in Saudi Arabia NK Alharbi, JA Al-Tawfiq, S Alghnam, A Alwehaibe, A Alasmari, ... Journal of Infection and Public Health 15 (5), 573-577, 2022 | 12 | 2022 |
| Immunogenicity of high-dose MVA-based MERS vaccine candidate in mice and camels NK Alharbi, F Aljamaan, HA Aljami, MW Alenazi, H Albalawi, A Almasoud, ... Vaccines 10 (8), 1330, 2022 | 11 | 2022 |
| Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia MA Abolfotouh, A Musattat, M Alanazi, S Alghnam, M Bosaeed BMC Infectious Diseases 22 (1), 950, 2022 | 10 | 2022 |
| Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia H AlQahtani, S AlBilal, E Mahmoud, O Aldibasi, A Alharbi, N Shamas, ... Journal of Infection and Public Health 15 (1), 36-41, 2022 | 10 | 2022 |
